skip to content
Primary navigation


Drug - Invega® (paliperidone)

June 2014

Therapeutic area - Mental Health

Approval criteria

  • Patient has been stabilized on Invega (the drug is part of the recipient's current course of treatment) as covered on a previous health insurance plan, and patient is new to MA OR
  • Patient was started and stabilized on Invega in an acute care setting, such as during a hospitalization or within another place of care that offers acute care services OR
  • Patient is 13 years of age or older AND
  • Patient has a diagnosis of schizophrenia and has failed to respond to, or experiences intolerable side effects, to Risperdal (risperidone)

Quantity limits

  • Invega 1.5 mg; 3 mg; 9 mg = 34 tablets per 34 days
  • Invega 6 mg = 68 tablets per 34 days


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top